Molecular typing is based on molecular genetic testing and isn't still routinely readily available. Molecular subtypes and immunohistochemical surrogate markers on the tumors (HR, HER2, triple detrimental) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-sixty seven might https://frankr642qzj2.wikimidpoint.com/user